New liquid painkiller combo for kids enters first human tests

NCT ID NCT07632274

Recruiting now Knowledge-focused Sponsor: HALEON Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 01, 2026 · Updated 3 times

Summary

This early-stage study will test a liquid medicine that combines two common pain relievers—ibuprofen and acetaminophen—in children aged 6 to 11. The goal is to measure how the body absorbs and processes the drugs, not to treat pain directly. Only 12 children who have recently had pain or a dental procedure will take a single dose, and researchers will track drug levels in their blood.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ibuprofen and acetaminophen liquid suspension
What this could lead to: If successful, this could provide dosing information needed to offer a convenient liquid combination pain reliever for children.
What could go wrong: This is a very early, small study (12 children) focused on drug levels, not on how well it works or safety. It may not lead to a new product.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PAIN

Contacts and locations

Locations

CenExel Salt Lake
RECRUITING

Salt Lake City, Utah, 84107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.